Recent news and posts
New procedure and diagnostic codes added to the private reimbursement schedule in England
In November 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, has published Bulletins 0180 and 0077 with changes to be implemented no later than February 01, 2022.
Four new procedure codes were introduced:
- 20390 Neuropsychological assessment;
- V4170 Distraction of traditional spinal growing rods for idiopathic juvenile scoliosis including spinal cord monitoring and imaging;
- X3592 Intravenous infusion of bone-strengthening drugs in cancer setting only;
- C6231 Laser Iridotomy - Bilateral.
Three new diagnostic codes were introduced:
- 20390 Neuropsychological assessment;
- 8601G Connective Tissue Gene Panel;
- 8601B Posaconazole level.
See the full details here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).